Brevital Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 42023-105

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Brevital Sodium (NDC 42023-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Brevital 1)

Chemical structure of methohexital sodium, the active ingredient in Brevital Sodium. The diagram shows the molecular structure with labeled atoms including carbon (C), hydrogen (H), nitrogen (N), oxygen (O), and sodium (Na).*

FDA Label Image

500 mg Vial (Brevital 2)

Label for Brevital Sodium injection powder, lyophilized for solution, 500 mg per vial. The label identifies methohexital sodium as the active ingredient and includes instructions noting it is an anesthetic barbiturate, preservative-free, and for multiple dose use. Manufacturer is Par Health USA, LLC, with storage and administration warnings. The label also provides the NDC 42023-105 and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.